Injectable alcoholism drug developed
A U.S. biotech firm has reportedly developed a monthly injectable alcoholism treatment as a substitute for a daily pill.
The drug -- being marketed by Cephalon Inc., in Frazer, Pa. -- was developed by Alkermes Inc. of Cambridge, Mass., as an extended-release injection form of naltrexone.
The new drug, Vivitrol, works by blocking neurotransmitters believed to be associated with alcohol dependence, diminishing the craving for alcohol, the Philadelphia Inquirer reported Tuesday.
Vivitrol has been approved by the U.S. Food and Drug Administration for use by adults able to abstain from drinking alcohol in an outpatient setting, and who are not actively drinking when they begin treatment.
The monthly intramuscular shot will cost $695, with Alkermes and Cephalon sharing profits from Vivitrol sales, as well as developing future commercial uses, possibly to treat other addictions.
Researchers told the Inquirer Vivitrol will be administered only by healthcare personnel in offices, hospitals, and clinics, and the treatment will include counseling.
Copyright 2006 by United Press International
-
From lemons to lemonade: Reaction uses carbon dioxide to make carbon-based semiconductor,
33 comments
-
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments,
3 comments
-
SpaceX private rocket blasts off for space station (Update),
42 comments
-
Landmark calculation clears the way to answering how matter is formed,
55 comments
-
Research team claims to have found evidence Lake Cheko is impact crater for Tunguska Event,
18 comments
More news stories
T cells 'hunt' parasites like animal predators seek prey, study shows
By pairing an intimate knowledge of immune-system function with a deep understanding of statistical physics, a cross-disciplinary team at the University of Pennsylvania has arrived at a surprising finding: T cells use a movement ...
Medicine & Health / Medical research
11 hours ago |
5 / 5 (4) |
0
|
Same gene that stunts infants' growth also makes them grow too big: research
UCLA geneticists have identified the mutation responsible for IMAGe* syndrome, a rare disorder that stunts infants' growth. The twist? The mutation occurs on the same gene that causes Beckwith-Wiedemann syndrome, which makes ...
11 hours ago |
not rated yet |
0
|
Almost half of new vets seek disability
(AP) -- America's newest veterans are filing for disability benefits at a historic rate, claiming to be the most medically and mentally troubled generation of former troops the nation has ever seen.
9 hours ago |
not rated yet |
0
Color-changing contact lenses to help diabetics (w/ Video)
For the millions of Americans with diabetes, the inconvenient and often painful method of testing blood sugar levels is a way of life. But research and innovative product design by scientists at The University of Akron may ...
May 23, 2012 |
4.4 / 5 (7) |
5
|
Missouri opts for untested drug for executions
(AP) -- The same anesthetic that caused the overdose death of pop star Michael Jackson is now the drug of choice for executions in Missouri, causing a stir among critics who question how the state can guarantee ...
Medicine & Health / Medications
May 24, 2012 |
not rated yet |
5
Stunning image of smallest possible five-ringed structure
Scientists have created and imaged the smallest possible five-ringed structure – about 100,000 times thinner than a human hair – and you'll probably recognise its shape.
'Unzipped' carbon nanotubes could help energize fuel cells, batteries
Multi-walled carbon nanotubes riddled with defects and impurities on the outside could replace some of the expensive platinum catalysts used in fuel cells and metal-air batteries, according to scientists at ...
Change in developmental timing was crucial in the evolutionary shift from dinosaurs to birds: study
At first glance, it's hard to see how a common house sparrow and a Tyrannosaurus Rex might have anything in common. After all, one is a bird that weighs less than an ounce, and the other is a dinosaur that ...
Computer model used to pinpoint prime materials for efficient carbon capture
When power plants begin capturing their carbon emissions to reduce greenhouse gases – and to most in the electric power industry, it's a question of when, not if – it will be an expensive undertaking.
Yale study concludes public apathy over climate change unrelated to science literacy
Are members of the public divided about climate change because they don't understand the science behind it? If Americans knew more basic science and were more proficient in technical reasoning, would public consensus match ...
Land and sea species differ in climate change response: study
(Phys.org) -- Marine and terrestrial species will likely differ in their responses to climate warming, new research by Simon Fraser University and Australia’s University of Tasmania has found.
